39 results
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
device reporting regulations, we are required to report to the FDA any incident in which information reasonably suggests that our product may have
S-1/A
EX-1.1
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
with the Blue Sky survey; (iv) all fees and expenses in connection with listing the Shares and Warrant Shares on Nasdaq; (v) the filing fees incident … , and the cost of aircraft and other transportation chartered in connection with the road show; and (ix) all other costs and expenses incident
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
. Under the FDA’s medical device reporting regulations, we are required to report to the FDA any incident in which information reasonably suggests
S-1
oy7do
13 Dec 23
IPO registration
5:30pm
8-K
EX-10.7
19m ojnfydfdu
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.8
8toqn
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-1.1
lpvpu92m zpjy
23 Aug 22
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
4:11pm
8-K
EX-10.1
uxk93256
25 Mar 22
Entry into a Material Definitive Agreement
3:00pm
8-K
EX-10.2
lelko88r882qk o63rq
23 Sep 21
Entry into a Material Definitive Agreement
9:16am
8-K
EX-10.1
brcjxqwi
23 Sep 21
Entry into a Material Definitive Agreement
9:16am
8-K
EX-1.1
qljv99ge
28 May 21
Entry into a Material Definitive Agreement
5:27pm
8-K
EX-10.2
eeoafs
28 Dec 20
Entry into a Material Definitive Agreement
2:30pm
8-K
EX-10.1
7uws5tpln
28 Dec 20
Entry into a Material Definitive Agreement
2:30pm